NCT03908034

Brief Summary

The purpose of this study is to examine (1) how the causal structure of a disease influences people's disease prevention decisions; and (2) how the causal structure of a disease interacts with people's regret anticipation in determining their disease prevention decisions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

April 4, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

April 9, 2019

Status Verified

April 1, 2019

Enrollment Period

3 months

First QC Date

April 2, 2019

Last Update Submit

April 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decision to remove X

    The decision to remove X (yes vs. no)

    Day 1: When responding to the questionnaire

Other Outcomes (3)

  • Anticipated regret

    Day 1: When responding to the questionnaire.

  • Judgment of whether the removal of X is an opportunity to improve earnings

    Day 1: When responding to the questionnaire.

  • Sense of control over the final outcome

    Day 1: When responding to the questionnaire.

Study Arms (4)

Uncontrollable factor ABSENT; NO anticipated regret induced

NO INTERVENTION

The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5 (Hong Kong dollars). Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash. There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. A cause, X, is identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points.

Uncontrollable factor ABSENT; anticipated regret induced

EXPERIMENTAL

Same description as in the "uncontrollable factor absent, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.

Other: induction of anticipated regret

Uncontrollable factor PRESENT; NO anticipated regret induced

EXPERIMENTAL

The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5. Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash. There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. Two causes, X and Y, are identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points.

Other: presence of uncontrollable risk factor

Uncontrollable factor PRESENT; anticipated regret induced

EXPERIMENTAL

Same as the "uncontrollable factor present, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.

Other: presence of uncontrollable risk factorOther: induction of anticipated regret

Interventions

the presence of an uncontrollable / unremovable risk factor for a disease

Uncontrollable factor PRESENT; NO anticipated regret inducedUncontrollable factor PRESENT; anticipated regret induced

higher level of elaboration on potential regret

Uncontrollable factor ABSENT; anticipated regret inducedUncontrollable factor PRESENT; anticipated regret induced

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • students enrolled in marketing courses at the Chinese University of Hong Kong

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Related Publications (1)

  • Binder S, Nuscheler R. Risk-taking in vaccination, surgery, and gambling environments: Evidence from a framed laboratory experiment. Health Econ. 2017 Dec;26 Suppl 3:76-96. doi: 10.1002/hec.3620.

    PMID: 29285871BACKGROUND

MeSH Terms

Conditions

Risk Reduction Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Wing Man Yeung, PhD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wing Man Yeung, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Each participant will only receive the instruction pertaining to the arm to which he/she is assigned. The Research Assistant who conducts the study does not know about the hypothesis.
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: The study has a 2 (presence of uncontrollable factor: yes vs. no) ✕ 2 (Anticipated regret induction: yes vs. no) between-subject design. Participants will be randomly assigned to one of the 4 between-subject conditions. There is also a within-subject variable. Each subject will respond to 10 rounds of decision task with 5 different levels of overall disease risk reduction brought by the removal of X. The 5 levels of risk reduction are: (i) Removal of X reduces disease risk from 60% to 50% ; (ii) 60% to 40%; (iii) 60% to 30%; (iv) 60% to 20%; (v) 60% to 10%.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Marketing

Study Record Dates

First Submitted

April 2, 2019

First Posted

April 9, 2019

Study Start

April 4, 2019

Primary Completion

July 1, 2019

Study Completion

July 1, 2019

Last Updated

April 9, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will share

Data will be uploaded to file sharing sites for sharing. Any identifying information will be removed before data sharing.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will become available after manuscript is published, for 5 years starting from publication date.
Access Criteria
Data will only be made available for research purpose.

Locations